Senate Pharmacy Benefits Managers and Consumer Access to Prescription Medications Study Committee; create

This bill creates a Senate study committee to investigate pharmacy benefits managers and their impact on prescription drug costs and consumer access. The committee will examine practices such as steering patients to affiliated pharmacies, drug price markups, and reimbursement manipulation that critics say harm patients and independent pharmacies. The committee consists of Senate committee chairs and appointed experts, and it will hold meetings, receive funding for its work, and submit a report with findings and potential legislative recommendations before being abolished on December 1, 2026.